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Owing to a production error the published Supplementary files 1 and 2 were incorrect. Supplementary file 1 was published with the legend for Supplementary file 2 and a file from another eLife article was published with the legend for Supplementary file 1.

The correct Supplementary files 1 and 2 are available here.

[Supplementary file 1](https://cdn.elifesciences.org/articles/19432/elife-19432-supp1-v1-download.xlsx). Includes qPCR primer sequences and UPL probe numbers for RT-qPCR experiments described in the manuscript.

[Supplementary file 2](https://cdn.elifesciences.org/articles/19432/elife-19432-supp2-v1-download.xlsx). Indicates the source of all cell lines used, as well as results of mycoplasma testing throughout the course of these studies.

The article has now been corrected accordingly.

Additional files {#s1}
================

###### Includes qPCR primer sequences and UPL probe numbers for RT-qPCR experiments described in the manuscript.

###### Indicates the source of all cell lines used, as well as results of mycoplasma testing throughout the course of these studies.
